Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Burning Mouth Syndrome
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Mild Cognitive Impairment, Dementia, Alzheimer's Disease
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 65 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Cognitive Change, Cognitive Impairment, Healthy Aging, Dementia
Interventions: Cognitive Training, Cognitive Stimulating Activities; Behavioral
Lead sponsor: Clemson University; Other
Eligibility: 65 Years to 90 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: State College, Pennsylvania

Conditions: Hepatic; Functional Disturbance
Interventions: NKTR-118; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Sleep Deprivation
Interventions: Controlled Dietary Intervention; Drug
Lead sponsor: St. Vincent's Medical Center; Other
Eligibility: 25 Years to 40 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: New York, New York

Conditions: Thyroid; Functional Disturbance
Interventions: Erythrosine, prepared in drinking water (0.69 mg/kg bw/day), SODIS-treated erythrosine, prepared in drinking water (0.69 mg/kg bw/day), Iodine, prepared in drinking water 0.075 mg/kg bw/day); Dietary Supplement
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Covid19, Anosmia, Olfactory Disorder, Covid-19 Pandemic, SARS-CoV-2 Infection, Hyposmia, Ageusia, Hypogeusia
Interventions: Theophylline Powder, Placebo Comparator; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Myotonic Dystrophy Type 2, Myotonic Dystrophy Type 1
Interventions: Non-interventional study; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 30 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Chronic Pain, Early Cognitive Decline
Interventions: Mindfulness-based cognitive therapy; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years to 120 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Uremic Pruritus
Interventions: CR845 0.5 mcg/kg; Drug
Lead sponsor: Cara Therapeutics, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 33
States / cities: Escondido, California • Riverside, California • San Diego, California + 26 more

Conditions: Pelvic Organ Prolapse, Rectocele, Bowel Dysfunction
Interventions: Defecation Posture Modification Device; Device
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Cincinnati, Ohio

Conditions: Right Ventricular Dysfunction, Hypoxia
Interventions: Ferrous sulfate 325mg; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 60 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2028 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Mild Cognitive Impairment
Interventions: Planning for the Future, Enhanced Medical Engagement, Confidence Building and Social Engagement, Physical Intervention, Medical Adherence; Behavioral
Lead sponsor: Allison Gibson; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Blood Transfusion, Endothelial Physiopathology, Nitric Oxide, Pulmonary Hypertension
Interventions: Red blood Cells auto-transfusion, Inhaled Nitric Oxide (iNO) administration; Procedure · Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Polypharmacy, Alzheimer's Disease and Related Dementias, Mild Cognitive Impairment
Interventions: Pharmacist-led deprescribing intervention; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 474 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Post-acute Sequelae of COVID-19, Long COVID
Interventions: Valacyclovir, Celecoxib, Paxlovid, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Cognitive Decline
Interventions: Behavioral Treatment; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 60 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Functional Gastrointestinal Disorders (FGIDs), Cyclic Vomiting Syndrome, Functional Dyspepsia, Dysautonomia
Interventions: Percutaneous electrical nerve field stimulation, Hypnotherapy; Device · Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 11 Years to 18 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Anxiety Disorder, Panic Disorder
Interventions: Clinical vestibular tests; Procedure
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 165 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2000
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Head and Neck Cancer, Taste Dysfunction
Interventions: Miraculin, Miracle Fruit Placebo Cube; Drug · Dietary Supplement
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cognitive Impairment, Mild, Depressive Symptoms, Anxiety
Interventions: Active Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS); Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 60 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: St Louis, Missouri

Conditions: Bipolar Disorder
Interventions: Galantamine, Placebos; Drug
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 18 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Depression, Mild Cognitive Impairment
Interventions: Donepezil, Placebo, Citalopram, Venlafaxine; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 55 Years to 95 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: New York, New York • Durham, North Carolina

Conditions: Pulmonary Disease, Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome

Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial

The Everyday Function Intervention Trial

Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function

A Change in Diet May Decrease the Negative Consequences of Chronic Sleep Deprivation

Photodegraded Edible Food Dyes

Smell in Covid-19 and Efficacy of Nasal Theophylline

Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2

Mindfulness-based Cognitive Therapy for the Chronic Pain-early Cognitive Decline Co-morbidity Among Older Black Individuals in the Community; The Feeling of Being Open Pilot

CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Impact of Defecation Posture on Ease of Bowel Movements in Patients With a Rectocele

Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia

Platform-based Mild Cognitive Impairment (MCI) Trial

Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting

ALIGN: Aligning Medications With What Matters Most (Demonstration)

SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction

Multicomponent Program for Addressing Cognition in Rural Communities

Autonomic Reactivity and Personalized Neurostimulation

Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia

Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy

Brain Stimulation and Enhancing Cognition in Older Adults

A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder

Combination Treatment Study for Memory Impairment and Depression

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension